(Q33366373)

English

Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors

scientific article

Statements

Safety and pharmacokinetic study of RPI.4610 (ANGIOZYME), an anti-VEGFR-1 ribozyme, in combination with carboplatin and paclitaxel in patients with advanced solid tumors (English)
Jennifer A Lockridge

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit